Lifeline Biotechnologies Market Cap

Lifeline Biotechnologies has a market cap or net worth of $2.61 million as of April 29, 2026. Its market cap has decreased by -33.33% in one year.

Market Cap

2.61M

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 2.61M, a decrease of -86.25%. That is a compound annual growth rate of -8.50%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	2.61M	-14.29%
Dec 31, 2025	3.04M	600.00%
Dec 31, 2024	434.89K	-35.07%
Dec 28, 2023	669.78K	-33.33%
Dec 30, 2022	1.00M	50.00%
Dec 31, 2021	669.78K	-60.00%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Vycor Medical	2.34M
CYduct Diagnostics	3.20M
Fuse Medical	1.95M
Vicarious Surgical	3.92M
Sonendo	1.58M
AI Maverick Intel	4.86M
Escalon Medical	1.26M
Odyssey Health	5.45M

Market Cap Rankings